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Abstract 
Background: To define relationship of chest x-ray 
abnormality with the diagnosis of lung cancer with a 
view to identify those at high risk of lung cancer. 
Methods: In  this descriptive study patients with 
suspicion of lung cancer , were included. Chest x-ray 
findings and final diagnosis of all the patients were 
recorded.  All patients had contrast enhanced chest 
CT-scan and bronchoscopic evaluation by the chest 
physician. Patients with peripheral lung lesions had 
CT guided lung biopsy. Open lung biopsy was 
organized for patients with lung lesions not 
approachable bronchoscopically and not suitable for 
CT-guided lung biopsy. Final diagnosis was 
recorded and patients were identified as having lung 
cancer or not on the basis of tissue biopsy. Patients 
with major systemic diseases including neurological 
disorders, cardiovascular disease, endocrine and 
autoimmune disease or diseases related to 
gastrointestinal, renal, haematological, 
dermatological or musculoskeletal system were 
excluded.  
Results: Out of 701 patients 45% were found to 
have lung cancer. Univariate analysis demonstrated 
that mass lesion was significantly more common in 
lung cancer and findings of normal x-ray, prominent 
hilum and fibrotic shadow significantly were less 
common (p<0.05). Multivariate analysis showed 
mass lesion as strong predictor, and normal chest x-
ray and fibrotic shadows as powerful negative 
predictors of lung cancer (p<0.05). 
Conclusion: Chest x-ray interpreted by an 
experienced radiologist as abnormal is neither a 
sensitive nor a specific tool to predict lung cancer 
except if a mass lesion is identified. 
Key Words: Lung; cancer; chest x-ray. 
 
Introduction 
      Lung cancer is the leading cause of cancer deaths 
all over the world.  1 Late recognition of disease is the 
foremost contributor towards failure in improving 
outcomes despite the availability of highly 
sophisticated investigations and management options.1 
Thoracic anatomy is speculated to be the major cause 
behind this; i-e-, a pulmonary nodule could grow for a 
considerable period of time and metastasize without 
the development of any symptom.  2  In general, of 100 
newly presenting patients with lung cancer, 80 will be 
inoperable at presentation and only 20 will proceed to 
attempted resection. The 5-year mortality rates for 
lung cancer therefore remains at approximately 85 to 
90%. 2  It is crucially important to define the patients 
with higher possibility of having lung cancer so that a 
timely diagnosis can provide a chance for cure. 
    In recent years, several attempts have been made to 
improve an early diagnosis. While features in history 
and physical examination can be useful indicators of 
the extent of disease, findings of chest x-ray can 
provide some useful information.  3 An understanding 
of features on chest x-ray in patients with lung cancer 
can possibly allow the earlier identification and 
possible resection of this common but deadly disease.  
 
Methods 
      In  this descriptive study 701 patients with the 
suspicion of lung cancer referred to rapid access chest 
clinic at Leighton hospital, Crewe, United Kingdom  
were included. Data was collected over a span of 7 
years and results of outcome were analyzed at the end 
in August 2013. All procedures followed were in 
accordance with the ethical standards of the 
responsible committee on human experimentation 
(institutional or regional) and compatible with the 
declaration of Helsinki 1975, as revised in 
2000.Individuals irrespective of gender, age ≥ 18 years 
(adults), with suspicion of lung cancer were included . 
Chest x-ray findings and final diagnosis of all the 
patients were recorded. Chest x-ray findings included 
mass lesions, prominent hilum, fibrosis, atelectasis, 
solitary nodule, COPD changes, consolidation, pleural 
effusion, cavitating lesion, raised hemi-diaphragm, ill 
defined lesion, multiple nodules, loss of volume, 
pleural plaques, lobar collapse, total lung collapse or 
normal chest x-ray. All patients had contrast enhanced 
chest CT-scan reported by the consultant radiologist 
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and bronchoscopic evaluation by the chest physician. 
Patients with peripheral lung lesions had CT guided 
lung biopsy. Open lung biopsy was organized for 
patients with lung lesions not approachable 
bronchoscopically and not suitable for CT-guided lung 
biopsy. Final diagnosis was recorded and patients 
were identified as having lung cancer or not on the 
basis of tissue biopsy.     Patients with major systemic 
diseases including neurological disorders, 
cardiovascular disease, endocrine and autoimmune 
disease or diseases related to gastrointestinal, renal, 
hematological, dermatological or musculoskeletal 
system were excluded.  
    Sample size was determined for hypothesis testing 
for the population proportion using STEPS sample size 
calculator. 4 It was calculated to be 174 while keeping 
level of significance at 5%, power of test at 95% and 
anticipated population proportion at 13%.5  p value 
less than 0.05 was taken as statistically significant. Chi-
square and t-test were used for univariate analysis. 
Sensitivities, specificities and positive predictive 
values were calculated.  
 
Results 
    Males constituted 51.5 % (n=361) and females were 
48.5% (n=340). Out of the 701 patients, 313 (45%) were 
found to have lung cancer. Mean age was 53 ± 2.3 
years. Univariate analysis demonstrated that mass 
lesion was significantly more common in lung cancer 
and findings of normal x-ray, prominent hilum and  
 
Table 1:Carcinoma Lung-Chest x-ray profile 
Finding Sensitivity Specificity 
Positive 
Predictive 
Value 
Probability 
Normal 2 94 18 0.003* 
Atelectasis 1 98 22 0.173 
Solitary nodule 3 97 41 0.719 
COPD changes 4 94 32 0.124 
Consolidation 16 79 38 0.088 
Mass lesion 59 88 79 0.001* 
Hilar prominence 3 92 20 0.001* 
Pleural effusion 10 92 48 0.619 
Cavitating lesion 3 98 59 0.234 
Raised 
hemidiaphragm 
3 98 50 0.643 
Ill defined lesion 2 96 26 0.068 
Multiple nodules 3 98 53 0.494 
Fibrosis 2 94 18 0.003* 
Loss of volume 7 96 55 0.176 
Pleural plaques 1 99 25 0.261 
Lobar collapse 2 98 47 0.874 
Total lung collapse 1 99 75 0.221 
* = significant. 
fibrotic shadow significantly were less common 
(p<0.05)(Table 1&2; Figure 1). Rest of the findings 
turned out to be insignificant. Multivariate analysis 
showed mass lesion as strong predictor, and normal 
chest x-ray and fibrotic shadows as powerful negative 
predictors of lung cancer (p<0.05)(Table 3).   
 
Table 2: Carcinoma Lung- Radiological 
Abnormality and Final Diagnosis 
CXR Abnormality 
Final Diagnosis 
p-value 
No Lung 
Cancer 
Lung 
Cancer 
Atelactasis 7(78%) 2(22%) 0.173 
Solitary Nodule 13(59%) 9(41%) 0.719 
Consolidation 83(62%) 51(38%) 0.088 
Mass Lesion 48(21% 184(79%) <0.001 
Hilar Prominence 32(80%) 8(20%) 0.001 
Cavitating Lesion 7(41%) 10(59%) 0.234 
Pleural Effusion 33(52%) 30(48%) 0.619 
Raised 
Hemidiaphragm 9(50%) 9(50%) 0.643 
Ill-defined lesion 17(74%) 6(26%) 0.068 
Multiple Nodules 7(47%) 8(53%) 0.494 
Fibrosis 23(82%) 5(18%) 0.003 
Loss of Volume 17(45%) 21(55%) 0.176 
Pleural 
plaques/calcification 6(75%) 2(25%) 0.261 
Lobar Collapse 8(53%) 7(47%) 0.874 
Total lung Collapse 1(25%) 3(75%) 0.221 
COPD  25(68%) 12(32%) 0.124 
 
 
 
Figure 1: Different findings on chest x-ray; only the ones that came 
out to have significance in the diagnosis of lung cancer on regression 
analysis are shown here. 1A: Normal CXR; 1B: Mass lesion in right 
upper lung field; 1C: Prominent right hilum; 1D: Fibrotic shadows in 
left lower lung field.  
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Table 3: Carcinoma Lung-Regression Analysis 
Finding 
Regression 
coefficient 
Odds Ratio 
(CI) 
Probability 
Normal -1.33 0.3 (0.1-0.5) 0.001* 
Mass lesion 2.03 7.6 (5-12) 0.001* 
Fibrosis -1.29 0.3 (0.1-0.8) 0.017* 
Prominent hilum -0.7 0.5 (0.2-1.1) 0.096 
Cavitating lesion 0.94 2.6 (0.9-7.1) 0.072 
Atelectasis -1.04 0.4 (0.1-1.9) 0.221 
Pleural effusion 0.42 1.5 (0.9-2.7) 0.156 
Total lung collapse 1.76 5.8 (0.6-57) 0.13 
Regression analysis showing probability against each 
radiological finding; * = significant. 
 
Discussion 
    Lung cancer is usually recognized late in its natural 
history. 1,2 Early identification is the cornerstone to 
complete cure. This is a however a difficult task. 3  The 
need for a risk prediction system for lung cancer is 
therefore unequivocal. The objective of present study 
was to devise a diagnostic tool based on chest x-ray 
findings for early detection of lung cancer so that it can 
both be effective as well as cost effective. The current 
evidence does not support screening for lung cancer 
with chest radiography or sputum cytology. Annual 
low-dose CT screening is associated with a reduction 
in lung cancer mortality in high-risk smokers but 
further data are required on the cost effectiveness of 
screening and the relative harms and benefits of 
screening across a range of different risk groups and 
settings. 6   
 
Figure 2: Algorithm to suggest diagnostic steps in 
evaluating a case suspicious of lung cancer 
 
Individuals at high risk of lung cancer who meet the 
criteria for CT screening should participate in an 
informed and shared decision-making process by 
discussing the potential benefits, harms, and 
uncertainties of screening with their physicians. 7 
It is uncertain for which duration screening should be 
continued, which screening modality is most 
appropriate and cost effective and what is the 
psychological impact in case of indeterminate 
findings.8 There is now evidence that LDCT in 
carefully selected high-risk populations can lead to 
better outcomes but the cost effectiveness of mass 
screening with LDCT is still unknown and chest x-ray 
remains the diagnostic tool of choice for suspected 
lung cancers. 8- 14 
 
Conclusion 
Chest x-ray interpreted by an experienced radiologist 
as abnormal is neither a sensitive nor a specific tool to 
predict lung cancer except if a mass lesion is identified. 
Further refinement of this tool is required to 
accommodate cases presenting at primary care level.  
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